Potential conflict of interest: The development of the UDysRS was supported by grants from the Michael J. Fox Foundation and EMD/Merck KGaA Pharmaceuticals. The Training Program was additionally supported by Santhera Pharmaceuticals. Final production, supplemental filming and editing expertise were provided by i3 Research, Inc. He has also consulted with Solvay Pharmaceuticals on the use of the UDysRS and Juvantia Pharmaceuticals and EMD/Merck KGaA in the development and analysis of data related to dyskinesia treatments.
Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations†
Article first published online: 22 MAR 2010
Copyright © 2010 Movement Disorder Society
Volume 25, Issue 9, pages 1131–1142, 15 July 2010
How to Cite
Colosimo, C., Martínez-Martín, P., Fabbrini, G., Hauser, R. A., Merello, M., Miyasaki, J., Poewe, W., Sampaio, C., Rascol, O., Stebbins, G. T., Schrag, A. and Goetz, C. G. (2010), Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations. Mov. Disord., 25: 1131–1142. doi: 10.1002/mds.23072
- Issue published online: 19 JUL 2010
- Article first published online: 22 MAR 2010
- Manuscript Accepted: 7 FEB 2010
- Manuscript Revised: 13 JAN 2010
- Manuscript Received: 2 JUN 2009
Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.